GLP-1 medications are prescription drugs, and any changes to your treatment plan should be discussed with your healthcare provider
For organizations navigating the GLP-1 landscape specifically, Cypris enables continuous monitoring of poly-agonist patent filings, delivery technology innovations, and combination therapy claims across global jurisdictions
They work by: Slowing stomach emptying Increasing insulin secretion Decreasing appetite Medications in this category include: Semaglutide (brand names: Ozempic, Wegovy) Liraglutide (Saxenda, Victoza) Tirzepatide (Mounjaro technically a dual GIP/GLP-1 agonist) In recent years, theyve been widely used off-label for weight losseven among women trying to conceive
These medications are effective in reducing the chances of major adverse cardiovascular events, such as cardiovascular death , non-fatal heart attacks , and strokes
FDA approves new drug treatment for chronic weight management, first since 2014
obesity rate from 39.9% in 2022 to 37% in 2025